Table 1.
Demographic, and Laboratory Characteristics of 1288 Patients With Idiosyncratic DILI.
| Mean ± Std. Deviation | Range | |
|---|---|---|
| Age (years) | 43 ± 16.5 | 1–86 |
| Sex (males: females) | 661 (51.4%): 627 (48.6%) | – |
| Duration (days) IQR |
27 (11–60) | 1–929 |
| Weight (kg) | 55 ± 14 | 34–106 |
| BMI | 22.0 ± 4.5 | 10.6–43.2 |
| Serum protein (g/dl) | 6.5 ± 2.4 | 2.0–82.0 |
| Serum albumin (g/dl) | 3.1 ± 0.7 | 0.6–5.2 |
| Total bilirubin (mg/dl) | 8.3 ± 10.0 | 0.13–44.0 |
| Direct bilirubin (mg/dl) | 5.6 ± 6.6 | 0.04–32.0 |
| AST IU/L IQR |
220 (119–438) | 28.7–7538 |
| ALT IU/L IQR |
241 (110–519) | 29–9115 |
| ALP IU/L IQR |
180 (123–287) | 25–2986 |
| GGT IU/L IQR |
130 (62.294) | 14–5964 |
| Serum creatinine (mg/dl) | 1.0 ± 0.8 | 0.13–10.2 |
| INR | 1.7 ± 1.5 | 0.50–19.3 |
| Hemoglobin (g/dl) | 11.2 ± 2.1 | 2.7–18.2 |
| WBC (/mm3) IQR |
8600 (6238–11500) | 1100–23020 |
| Platelets 105/dl) | 2.3 ± 1.1 | .15–9.0 |
| MELD | 18.7 ± 8.8 | 6–56 |
Abbreviations: ATD: anti-tuberculosis drugs, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, BMI: Body Mass Index, GGT: gamma glutamyl transferase, INR: International normalized ratio, IQR: inter quartile range, MELD: Model for end stage liver disease, WBC: white blood cells.